Image of a Woman
Take charge
of PI on
your terms.
Take charge of PI
on your terms.


Living with PI and treating it can be challenging.

CUVITRU [Immune Globulin Subcutaneous (Human)] 20% can help by putting you and your doctor in charge of your treatment. Whether you’re switching from another subcutaneous (subQ) immunoglobulin or intravenous immunoglobulin (IVIg) treatment, CUVITRU is a customizable treatment option to help your body protect you from infection.1,2

What is the difference between subcutaenous
and intravenous treatments?

  • Subcutaneous (subQ)
    treatments are given
    under the skin1

    • CUVITRU can only be
      administered subcutaneously in
      the abdomen, thighs, upper
      arms, and/or lower back.1
    subQ needle
    subQ needle

    Subcutaneous (or “subQ”) administration1,4

    • Ig enters the body through the subQ tissue
      —which is a layer of tissue between the skin
      and the muscle—through use of a
      pump and a small, thin subQ needle
    • After training, you can administer at home
  • Intravenous immunoglobulin (IVIg) treatments are given directly into a vein3

    IVIg needle
    IVIg needle

    Intravenous (or “IVIg”) administration4

    • Ig enters the body through a vein in the
      hand or arm, through use of an IV needle
    • Healthcare providers (HCPs) administer
      at an infusion center or physician’s office

Needle sizes may vary. Graphics are for illustrative purposes only.

Getting started with CUVITRU

Switching from IVIg treatment? Your first CUVITRU infusion would be 1 week after your last IVIg treatment and follows the steps below.1

  1. Your doctor determines the dosage1

  2. Your dosing is adjusted based on your1

    • Clinical needs
    • How you respond to treatment
  3. With subQ infusions, your healthcare team can customize the1

    • Frequency
    • Number of infusion sites
    • Infusion volume per site
    • Infusion rate
  4. After your healthcare team teaches you how, you can begin self-infusing at home1

    • Your doctor and you will decide if self-administration is right for you
  • Infusion Icon
  • The ABCs of

    See what supplies are needed to complete your infusions, plus watch a video and download instructions on how to administer CUVITRU.

    Learn more
  • See how
    CUVITRU helped
    Julie and Walter

    Julie and Walter discussed their administration
    options with their doctors to find a plan to fit
    their lifestyles.

  • CUVITRU® patients Julie and Walter
Read Patient Stories
  1. CUVITRU [Prescribing Information]. Lexington, MA: Baxalta US Inc.
  2. Paris K, Haddad E, Borte M, et al. Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies. Immunotherapy. 2019;11(5):397-406.
  3. American Academy of Allergy, Asthma & Immunology. Preparing for intravenous immunoglobulin (IVIg) infusion therapy. Accessed July 1, 2019.
  4. Younger ME, Buckley RH. IDF Guide for Nurses: Immunoglobulin Therapy for Primary Immunodeficiency Diseases. 4th ed. Towson, MD: Immune Deficiency Foundation; 2016.